Beth Israel Med Ctr / Peter Krueger Clinic

This page covers the site record Beth Israel Med Ctr / Peter Krueger Clinic in New York, New York, United States: the trials that list it by this name in ClinicalTrials.gov. The same place can be registered under other names, each with its own page and its own trials, and a count here is a number of registered trials, not of patients enrolled.

Get the Beth Israel Med Ctr / Peter Krueger Clinic report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Work email

Company website

I'd like to receive the requested report and occasional related emails from Pharma Observatory. I can unsubscribe at any time.

Recent trials

The newest registered trials that list this site. Each title opens its ClinicalTrials.gov record.

• A Randomized, Double-Blind Study of 566C80 Versus Septra (Sulfamethoxazole/Trimethoprim) for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients NCT00000655·Phase 2·Completed·No start date
• A Phase II Efficacy Study Comparing 2',3'-Dideoxyinosine (ddI) (BMY-40900) and Zidovudine Therapy of Patients With HIV Infection Who Have Been on Long Term Zidovudine Treatment NCT00000671·Phase 2·Completed·No start date
• An Efficacy Study of 2',3'-Dideoxyinosine (ddI) (BMY-40900) Administered Orally Twice Daily to Zidovudine Intolerant Patients With AIDS or AIDS-Related Complex NCT00000672·Phase 2·Completed·No start date
• A Multi-Center Clinical Trial To Evaluate Azidothymidine (AZT) in the Treatment of Human Immunodeficiency Virus (HIV) Infection in Patients With AIDS Post First Episode PCP NCT00000700·Phase 3·Completed·No start date
• A Multicenter Placebo-Controlled Double-Blind Trial to Evaluate Azidothymidine (AZT) Treatment of the AIDS Dementia Complex and Central Nervous System (CNS) Human Immunodeficiency Virus (HIV) Infection NCT00000702·Phase 3·Completed·No start date

Showing 5 of 15 trials.

Start your 14-day trial Email me all 15 trials as a PDF

Lead sponsors

Most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

• National Institute of Allergy and Infectious Diseases (NIAID) 12 trials
• Bayer 1 trial
• Liposome 1 trial
• Pfizer 1 trial

Conditions studied

The specific conditions of the trials that list this site, most trials first.

• HIV Infections 15 trials
• Acquired Immunodeficiency Syndrome 10 trials
• AIDS-Related Complex 6 trials
• Opportunistic Infections 5 trials
• AIDS-Related Opportunistic Infections 5 trials

Showing 5 of 13 conditions.

Start your 14-day trial Email me all 13 conditions as a PDF